臨床外科70巻7号

2015年07月発行

特集 Neoadjuvant therapyの最新の動向—がんの治療戦略はどのように変わっていくのか

がん種別：術前補助療法の臨床的意義と今後の方向性

大腸癌に対するneoadjuvant therapy

著者： 森健¹ 清松知充¹ 渡邉聡明¹

所属機関： ¹東京大学医学部腫瘍外科

ページ範囲：P.828 - P.832

文献概要

【ポイント】
◆切除不能大腸癌に対して化学療法を行い，手術可能となるconversion therapyが注目されている．
◆下部直腸癌に対する術前化学放射線療法は，局所再発の軽減，機能温存，生存率に寄与する可能性がある．
◆切除可能な大腸癌に対する術前補助化学療法は，現状ではエビデンスの乏しい領域であり，今後の症例の蓄積が望まれる．

参考文献

1）Dahlberg M, Glimelius B, Pahlman L：Improved survival and reduction in local failure rates after preoperative radiotherapy：evidence for the generalizability of the result s of Swedish Rectal Cancer Trial. Ann Surg 229：493-497, 1999

2）Kapiteijn E, Marijnen CA, Nagtegaal ID, et al：Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345：638-646, 2001

3）Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al：Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93：1215-1223, 2006

4）Nagawa H, Muto T, Sunouchi K, et al：Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44：1274-1280, 2001

5）大腸癌研究会（編）：大腸癌治療ガイドライン　医師用2014年版．金原出版，2014

6）Power DG, Kemeny NE：Chemotherapy for the conversion of unresectable colorectal cancer liver metastasis to resection. Crit Rev Oncol Hematol 79：251-264, 2011

7）Adam R, Delvart V, Pascal G, et al：Rescue surgery for unresectable colorectal liver metastasis downstaged by chemotherapy：a model to predict long-term survival. Ann Surg 240：644-657, 2004

8）Adam R, Wicherts DA, de Hass RJ, et al：Patients with initially unresectable colorectal liver metastases：is there a possibility of cure? J Clin Oncol 27：1829-1835, 2009

9）Fernandez-Martos C, Pericay C, Aparicio J, et al：Phase Ⅱ, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin （CAPOX） compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer：Grupo Cancer de Recto 3 study. J Clin Oncol 28：859-865, 2010

10）Nogue M, Salud A, Vicente P, et al：Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer：the AVACROSS study. Oncologist 16：614-620, 2011

11）Dewdney A, Cunningham D, Tabemero J, et al：Multicenter randomized phase Ⅱ clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer（EXPERT-C）. J Clin Oncol 30：1620-1627, 2012

12）Swedish Rectal Cancer Trial：Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336：980-987, 1997

13）Spida F, Chessin DB, Shia J, et al：A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 13：1047-1053, 2006

14）Yeo SG, KIM DY, Park JW, et al：Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82：e193-199, 2011

15）O' Connell MJ, Colangelo LH, Beart RW, et al：Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer：surgical end points from National Surgical Adjuvant Breast and BOWEL Project trial R-04. J Clin Oncol 32：1927-1934, 2014

16）Lee SU, Kim DY, Kim SY, et al：Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer：capecitabine alone versus capecitabine plus irinotecan. Radiat Oncol 8：258, 2013

17）Spigel DR, Bendell JC, McCleod M, et al：Phase Ⅱ study of bevacizumab and chemoradiation in the preoperative of adjuvant treatment of patients with stage Ⅱ/Ⅲ rectal cancer. Clin Colorectal Cancer 11：45-52, 2011

18）Das P, Skibber JM, Rodriguez-Bigas MA, et al：Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109：1750-1755, 2007

19）Watanabe T, Komuro Y, Kiyomatsu T, et al：Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66：3370-3374, 2006

20）Braendengen M, Tveit KM, Berglund A, et al：Randomized phase Ⅲ study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26：3687-3694, 2008

21）Schrag D, Weiser MR, Goodman KA, et al：Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer：a pilot trial. J Clin Oncol 32：513-518, 2014

22）Bokemeyer C, Bondarenko I, Makhson A, et al：Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 27：663-671, 2009

23）Foxtrot Collaborative Group：Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer：the pilot phase of a randomised controlled trial. Lancet Oncol 13：1152-1160, 2012